1: Iimura H, Takeuchi T, Kondo S, Matsuzaki M, Umezawa H. Dopastin, an inhibitor of dopamine -hydroxylase. J Antibiot (Tokyo). 1972 Aug;25(8):497-500. doi: 10.7164/antibiotics.25.497. PMID: 4648494.
2: Stadler M, Monticelli S, Seidel T, Luger D, Salzer I, Boehm S, Holzer W, Schwarzer C, Urban E, Khom S, Langer T, Pace V, Hering S. Design, Synthesis, and Pharmacological Evaluation of Novel β2/3 Subunit-Selective γ-Aminobutyric Acid Type A (GABAA) Receptor Modulators. J Med Chem. 2019 Jan 10;62(1):317-341. doi: 10.1021/acs.jmedchem.8b00859. Epub 2018 Oct 23. PMID: 30289721.
3: Shiino M, Watanabe Y, Umezawa K. Synthesis of N-substituted N-nitrosohydroxylamines as inhibitors of mushroom tyrosinase. Bioorg Med Chem. 2001 May;9(5):1233-40. doi: 10.1016/s0968-0896(01)00003-7. PMID: 11377181.
4: Stadler RH, Verzegnassi L, Varga N, Grigorov M, Studer A, Riediker S, Schilter B. Formation of vinylogous compounds in model Maillard reaction systems. Chem Res Toxicol. 2003 Oct;16(10):1242-50. doi: 10.1021/tx034088g. PMID: 14565766.
5: Magenheimer BS, St John PL, Isom KS, Abrahamson DR, De Lisle RC, Wallace DP, Maser RL, Grantham JJ, Calvet JP. Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter- dependent cystic dilation. J Am Soc Nephrol. 2006 Dec;17(12):3424-37. doi: 10.1681/ASN.2006030295. Epub 2006 Nov 15. PMID: 17108316.
6: Yuan Y, Bai L, Nan J, Liu J, Luan X. Regiospecific Ficini [2 + 2] cycloaddition of ynamides with cyclic isoimidium salts under catalyst-free conditions. Org Lett. 2014 Aug 15;16(16):4316-9. doi: 10.1021/ol5020587. Epub 2014 Aug 7. PMID: 25102092.
7: Xu XD, Zhang XZ, Wang B, Cheng SX, Zhuo RX, Wang ZC. Fabrication of a novel temperature sensitive poly(N-isopropyl-3-butenamide) hydrogel. Colloids Surf B Biointerfaces. 2007 Oct 1;59(2):158-63. doi: 10.1016/j.colsurfb.2007.05.005. Epub 2007 May 22. PMID: 17576053.